The Senior Safety Scientist within Global Patient Safety Science is an individual contributor providing safety science and pharmacovigilance support across Revolution Medicines' RAS(ON) inhibitor portfolio for RAS-addicted cancers. Revolution Medicines is a commercial-stage oncology company developing oral RAS(ON) tri-complex inhibitors.
Text as published by the employer. Always confirm details on the employer's site.